New zebrafish model should speed research on parasite that causes toxoplasmosis

May 15, 2015, Oregon State University
Toxoplasma gondii. Credit: Wikipedia

Researchers at Oregon State University have found a method to speed the search for new therapies to treat toxoplasmosis – by successfully infecting zebrafish with Toxoplasma gondii.

The findings were just published in the Journal of Fish Diseases, in work supported by the Tartar Foundation and the National Institutes of Health.

T. gondii, a , can infect a wide range of hosts, and is one of the most prevalent parasites in the world. It has been estimated to infect about one-third of the human race. Treatment can be difficult because parasites often have biologic similarities to the hosts they infect.

Zebrafish have been found in recent years to be an excellent model for biomedical research because they reproduce rapidly, bear many similarities to and biological systems, and can be used in "high throughput" technologies to literally test hundreds of compounds in a fairly short period of time.

"This advance may provide a very efficient tool for the discovery of new therapies for this parasitic infection," said Justin Sanders, an OSU postdoctoral fellow and lead author on the study. "With it we should be able to more easily screen a large library of compounds, at much less expense, and look at things that are unknown or have never been considered as a possible treatment."

Although it infects many animals, T. gondii infection has never been observed prior to this in fish. But the OSU researchers found that by raising the temperature of the water in which lived to a warmer-than-normal 98.6 degrees, or the temperature of a human body, they could become infected with the parasite but also survive.

"T. gondii affects a wide range of mammals and birds, and cats are actually one of the most routine hosts," said Michael Kent, a professor of microbiology in the OSU College of Science. "It can cause congenital defects, which is one reason that pregnant women are told not to clean the catbox. Many people become infected for life. These chronic infections can cause serious eye disease and can be fatal to people with weakened immune systems.

"New therapies would clearly be of value, and now we have a better way to find them," he said.

Explore further: New research offers the potential of new treatments for toxoplasma-induced pneumonia and cystic fibrosis

More information: "The zebrafish, Danio rerio, as a model for Toxoplasma gondii: an initial description of infection in fish." Journal of Fish Diseases. doi: 10.1111/jfd.12393

Related Stories

New research offers the potential of new treatments for toxoplasma-induced pneumonia and cystic fibrosis

April 29, 2015
The research has discovered a link between a vital pumping system that does not function correctly in people with cystic fibrosis and the parasite Toxoplasma.

Statin, osteoporosis drug combo may help treat parasitic infections

October 17, 2013
Researchers at the University of Georgia have discovered that a combination of two commonly prescribed drugs used to treat high cholesterol and osteoporosis may serve as the foundation of a new treatment for toxoplasmosis, ...

Hitting parasites where they hurt: New research shows promise in the fight against Toxoplasmosis

May 21, 2012
Toxoplasmosis, a disease caused by the parasite Toxoplasma gondii, is one of the most common parasitic infections in the world. In the U.S. it is estimated that more than 22 percent of the population 12 years and older have ...

Recommended for you

First proof a synthesized antibiotic is capable of treating superbugs

March 23, 2018
A "game changing" new antibiotic which is capable of killing superbugs has been successfully synthesised and used to treat an infection for the first time—and could lead to the first new class of antibiotic drug in 30 years.

Scientists identify potential drug target in blood-feeding hookworms

March 22, 2018
In hookworms that infect and feed on the blood of mice, scientists have discovered a key step in blood digestion that can be targeted to disrupt the parasite's development and survival. These findings, published in PLOS Pathogens ...

Global burden of low back pain—a consequence of negligence and misinformation

March 21, 2018
A series of groundbreaking papers from Australian and international researchers in The Lancet, published today (22/3) warns that low back pain is a major health burden globally - across developed and developing nations - ...

Microscopic 'shuttles' transport enzyme from cells to trigger onset of kidney disease

March 21, 2018
A new study involving the University of Sheffield has identified a key culprit in the onset of kidney disease in a major marker for kidney disease development.

Metabolite therapy proves effective in treating C. difficile in mice

March 20, 2018
A team of UCLA researchers found that a metabolite therapy was effective in mice for treating a serious infection of the colon known as Clostridium difficile infection, or C. difficile.

Study of COPD patients has created a 'looking glass' into genome of pathogen

March 19, 2018
Decades of work on chronic obstructive pulmonary disease (COPD) at the University at Buffalo and the Veterans Affairs Western New York Healthcare System have yielded extraordinary information about the pathogen that does ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.